Ophthalmic Viscoelastic Devices Market Expansion Is Opening New Pathways For Strategic Investment
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
The ophthalmic viscoelastic devices market is steadily evolving, driven by advancements in eye care and an increasing volume of surgical procedures worldwide. This sector is witnessing consistent growth due to rising demand for improved surgical outcomes and expanding access to ophthalmic treatments. Let’s explore the market’s current size, key growth factors, leading players, and regional insights.
Steady Expansion in Ophthalmic Viscoelastic Devices Market Size
The market for ophthalmic viscoelastic devices has shown steady growth in recent years. It is forecasted to increase from $2.72 billion in 2025 to $2.85 billion in 2026, representing a compound annual growth rate (CAGR) of 4.7%. This rise during the past period has been primarily driven by the growing prevalence of cataract surgeries, an aging demographic, wider adoption of intraocular surgical procedures, the expansion of ophthalmology clinics, and improved access to eye care services globally. Looking ahead, the market is expected to continue its upward trajectory, reaching $3.47 billion by 2030 with an anticipated CAGR of 5.1%. Factors contributing to this growth include an increased demand for premium surgical outcomes, a focus on reducing complications, the growth of advanced ophthalmic surgery centers, enhanced investments in eye care infrastructure, and the adoption of innovative viscoelastic materials. Emerging trends in the coming years are likely to include wider use of advanced viscoelastic formulations, rising interest in dual-property ophthalmic viscoelastic devices (OVDs), heightened attention on tissue protection, expansion of minimally invasive surgeries, and improvements in shelf stability and biocompatibility.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10665&type=smp
Increasing Number of Ophthalmic Surgeries Fuels Market Demand
The expanding volume of ophthalmic surgeries is a significant factor propelling the ophthalmic viscoelastic devices market. These surgeries encompass a range of eye-related procedures such as cataract surgery, corneal transplants, and retinal detachment repairs. Ophthalmic viscoelastic devices serve important roles during these operations by maintaining space, protecting sensitive eye tissues, facilitating surgical maneuvers, and improving surgical visualization thanks to their unique viscous and elastic properties. These benefits contribute to better surgical outcomes and reduce complications like tissue trauma and intraoperative injury. For instance, data from May 2023 by the UK’s National Health Service reveals that cataract surgeries account for 6% of all surgeries performed annually, with over 450,000 procedures conducted each year. Projections suggest this number will rise by 25% by 2027 and surge by 50% by 2035, highlighting a robust increase in demand for ophthalmic viscoelastic devices.
Technological Advances Shaping Ophthalmic Viscoelastic Devices Market
Innovation plays a critical role in the competitive dynamics of the ophthalmic viscoelastic devices market. Key players are focusing on cutting-edge technologies to enhance surgical precision and patient outcomes. One such advancement is the development of line implant-free system solutions, which improve medical procedures without invasive implants, offering less intrusive treatment options. For example, in April 2023, Bausch + Lomb Corporation introduced the StableVisc cohesive ophthalmic viscosurgical device (OVD) alongside the TotalVisc Viscoelastic System. StableVisc is designed to maintain space in the eye’s anterior chamber, enabling surgeons to safely remove and replace a cloudy natural lens. The TotalVisc system combines StableVisc with ClearVisc, a dispersive OVD that protects ocular tissue throughout surgery. These products contain sodium hyaluronate and sorbitol, a distinctive compound that laboratory studies have shown to provide superior free radical scavenging compared to other OVDs. As a result, the TotalVisc system offers dual-action protection through both mechanical and chemical means.
Access The Complete Ophthalmic Viscoelastic Devices Market Report:
Market Segmentation Highlights for Ophthalmic Viscoelastic Devices
This report segments the ophthalmic viscoelastic devices market into key categories to provide detailed insights:
1) By Product Type: Cohesive Ophthalmic Viscoelastic and Dispersive Ophthalmic Viscoelastic
2) By Application: Cataract Surgery, Glaucoma Surgery, Corneal Transplant, and Vitreoretinal Surgery
3) By End User: Hospitals, Ophthalmology Clinics, and Other End Users
Further subsegments include types of cohesive OVDs such as sodium hyaluronate and hyaluronic acid, as well as dispersive OVDs like sodium chondroitin sulfate and dispersive hydrogel, offering a comprehensive view of product variations in the market.
Prominent Companies Leading the Ophthalmic Viscoelastic Devices Market
The ophthalmic viscoelastic devices market features several key players actively shaping its landscape. Leading companies include Altacor Ltd., Bausch Health Companies Inc., Bohus Biotech AB, Carl Zeiss Meditec AG, Haohai Biological Technology Co. Ltd., Johnson & Johnson Pvt. Ltd., Novartis International AG, Rumex International Corporation, Rayner Intraocular Lenses Limited, Aurolab, Alcon Inc., Beaver-Visitec International, Neu Micromed International Pvt. Ltd., Abbott Medical Optics, Maxigen Biotech Inc., Amring Pharmaceuticals Inc., Croma Pharma GmbH, Medicontur Medical Engineering Ltd., Rhein Medical Inc., MicroSurgical Technology, FCI Ophthalmics Inc., Hanita Lenses Ltd., and HOYA Medical Singapore Pte. Ltd. These companies are investing in innovation and expanding product portfolios to meet the evolving needs of the ophthalmic surgical community.
Regional Market Leadership and Growth Outlook for Ophthalmic Viscoelastic Devices
In 2025, North America held the largest share of the ophthalmic viscoelastic devices market, demonstrating its established position in eye care innovation and infrastructure. Meanwhile, the Asia-Pacific region is expected to record the fastest growth during the forecast period, driven by increasing healthcare investments and expanding ophthalmic surgical centers. The market analysis encompasses important regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, offering a comprehensive perspective on the global ophthalmic viscoelastic devices industry.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
